Research Journal of Biological Sciences

Year: 2009
Volume: 4
Issue: 6
Page No. 668 - 674

Genes Expression in Biosynthesis Lipopolysaccharide of Burkholderia pseudomallei the Causative Agent of Melioidosis

Authors : Nagi A. Al-Haj, Lai L. Suang, Mariana N. Shamsudin, Rasedee Abdullah, Rahmah Mohamed and Zamberi Sekawi

References

Brett, P.J. and D.E. Woods, 1996. Structural and immunological characterization of Burkholderia pseudomallei O-polysaccharide-flagellin protein conjugates. Infect. Immunity, 64: 2824-2828.
Direct Link  |  

Brett, P.J. and D.E. Woods, 2000. Pathogenesis of and immunity to melioidosis. Acta Trop., 74: 201-210.
PubMed  |  

Brett, P.J., D.C. Mah and D.E. Woods, 1994. Isolation characterization of Pseudomonas pseudomallei flagellin proteins. Infect. Immunity, 62: 1914-1919.
PubMed  |  

Charuchaimontri, C., Y. Suputtamongkol, C. Nilakul, W. Chaowagul and P. Chetchotisakd et al., 1999. Antilipopolysaccharide II: An antibody protective against fatal melioidosis. Clin. Infect. Dis., 29: 813-818.
PubMed  |  Direct Link  |  

David, D.S., J.B. Paul and E.W. Donald, 1998. The type II O-antigenic polysaccharide moiety of Burkholderia pseudomallei lipopolysaccharide is required for serum resistance and virulence. Mol. Microbiol., 30: 1081-1100.
PubMed  |  Direct Link  |  

Joyce, S.P., M. Katherine, P.J. Michael, M.A.J. Gidney and S. Lacelle et al., 1999. Conservation and accessibility of an inner core lipopolysaccharide epitope of Neisseria meningitidis. Infec. Immunity, 67: 5417-5426.
PubMed  |  

Kishore, R.S., K.S. Meena and T.K.C. Vincent, 2004. A novel genomics approach for the identification of drug targets in pathogens, with special reference to Pseudomonas aeruginosa. Silico Biol., 4: 28-28.
PubMed  |  

Matthias, T., R. Markus, R. Tomislav, K.H. Thomas, S.C. Alan, M. Reinhard and W. Chris, 1997. O-antigen seroepidemiology of Klebsiella clinical isolates and implications for immunoprophylaxis of Klebsiella infections. Clin. Diagn. Lab. Immunol., 4: 550-555.
PubMed  |  

Moriyon, I., J. Grillo, D. Monreal, D. Gonzalez and C. Marin et al., 2004. Rough vaccines in animal brucellosis: Structural and genetic basis and present status. Vet. Res., 35: 1-38.
PubMed  |  Direct Link  |  

Raetz, C.R.H. and W. Chris, 2002. Lipopolysaccharide entotoxin. Ann. Rev. Biochem., 71: 635-700.
PubMed  |  Direct Link  |  

Raetz, C.R.H., 1998. Enzymes of Lipid a Biosynthesis: Targets for the Design of New Antibiotics. In: Endotoxin and Sepsis, Jack, L. (Ed.). Wiley-Liss, A John Wiley and Son, Inc., USA., pp: 1-14.

Rietschel, E.T., T. Kirikae, F.U. Sxhade, U. Mamat and G. Schmidt et al., 1994. Bacterial endotoxin: Molecular relationships of structure to activity and function. FASEB J., 8: 217-225.
PubMed  |  

Rocchetta, H.L., L.L. Burrows and J.S. Lam, 1999. Genetic of O-antigen biosynthesis in Pseudomonas aeruginosa. Microbiol. Mol. Biol. Rev., 63: 523-553.
PubMed  |  

Shin-ichi, Y., A. Ken-ichi, H. Shunji, K. Toru, F. Nobuhiro and Y. Takashi, 1998. Human antibody response to Helicobacter pylori lipopolysaccharide: Presence of an immunodominant epitope in the polysaccharide chain of lipopolysaccharide. Infect. Immunity, 66: 3006-3011.
PubMed  |  

Walsh, A.L., M.D. Smith, V. Wuthiekanun, Y. Suputtamongkol and W. Chaowagul et al., 1995. Prognistic significance of quantitative bacteremia in septicemic melioidosis. Clin. Infec. Dis., 21: 1498-1500.
PubMed  |  Direct Link  |  

Woods, D.E., D. de Shazer, R.A. Moore, J.B. Paul, N.B. Mary, L.R. Shauna and D.S. Michelle, 1999. Current studies on the pathogenesis of melioidosis. Microbes Infect., 2: 157-162.
PubMed  |  

Design and power by Medwell Web Development Team. © Medwell Publishing 2021 All Rights Reserved